J Poirier1, S Kubow1, M Noël2, C Dupont3, G M Egeland4. 1. Center for Indigenous Peoples' Nutrition and Environment (CINE) & School of Dietetics and Human Nutrition, McGill University, 21,111 Lakeshore, St-Anne-de-Bellevue, Québec, H9X 3V9, Canada. 2. University of Ottawa, 25 Université (Room 140), Ottawa, Ontario, K1N 7K4, Canada. 3. Unité de recherche en santé publique, Université Laval, 2875 Boulevard Laurier, Édifice Delta 2, Bureau 600, Québec, Québec G1V 2M2, Canada. 4. Division of Epidemiology, Norwegian Institute of Public Health & Department of Global Public Health and Primary Care, University of Bergen, Kalfarveien 31, N-5018 Bergen, Norway. Electronic address: g.egeland@igs.uib.no.
Abstract
BACKGROUND AND AIMS: For primary prevention of cardiovascular disease (CVD), Canadian guidelines recommend that asymptomatic Canadians with abdominal obesity undergo Framingham risk score (FRS) assessment, and that in Indigenous Peoples, indicators of metabolic syndrome also be used to identify at-risk individuals. The hypertriglyceridemic-waist phenotype (HTGW) has been proposed to be a surrogate marker of visceral obesity and a simple proxy measure for metabolic syndrome. The primary aim of this study was to evaluate whether the HTGW and the FRS associated with sub-clinical atherosclerosis. METHODS AND RESULTS: Asymptomatic Cree participants in a cross-sectional study conducted 2005-2009 (n = 446, 18-81 y) were assessed for the HTGW using NCEP-ATP-III gender-specific-cutoffs (waist circumference: for men, ≥102 cm; for women ≥88 cm) and fasting triglycerides ≥1.7 mmol/L. Sub-clinical atherosclerosis was defined by the presence of a high sex-specific common-carotid-intimal-medial-wall-thickness (≥75th percentile). HTGW was present in 26.7% and a 10-y FRS greater than 10% was present in 18.8% of participants. The multivariate adjusted OR (95% CI) for sub-clinical atherosclerosis associated with an FRS greater than 10% was 4.10 (2.20-7.50) while that associated with the HTGW phenotype was 1.74 (95% CI 1.61-1.88) from a model including age, body mass index, alcohol consumption, FRS and the HTGW. CONCLUSIONS: The HTGW phenotype is prevalent in the Cree. Our findings support further study on the utility of combining the HTGW with the FRS in the prediction of cardiovascular disease outcomes and in health screening and intervention programs among indigenous peoples.
BACKGROUND AND AIMS: For primary prevention of cardiovascular disease (CVD), Canadian guidelines recommend that asymptomatic Canadians with abdominal obesity undergo Framingham risk score (FRS) assessment, and that in Indigenous Peoples, indicators of metabolic syndrome also be used to identify at-risk individuals. The hypertriglyceridemic-waist phenotype (HTGW) has been proposed to be a surrogate marker of visceral obesity and a simple proxy measure for metabolic syndrome. The primary aim of this study was to evaluate whether the HTGW and the FRS associated with sub-clinical atherosclerosis. METHODS AND RESULTS: Asymptomatic Cree participants in a cross-sectional study conducted 2005-2009 (n = 446, 18-81 y) were assessed for the HTGW using NCEP-ATP-III gender-specific-cutoffs (waist circumference: for men, ≥102 cm; for women ≥88 cm) and fasting triglycerides ≥1.7 mmol/L. Sub-clinical atherosclerosis was defined by the presence of a high sex-specific common-carotid-intimal-medial-wall-thickness (≥75th percentile). HTGW was present in 26.7% and a 10-y FRS greater than 10% was present in 18.8% of participants. The multivariate adjusted OR (95% CI) for sub-clinical atherosclerosis associated with an FRS greater than 10% was 4.10 (2.20-7.50) while that associated with the HTGW phenotype was 1.74 (95% CI 1.61-1.88) from a model including age, body mass index, alcohol consumption, FRS and the HTGW. CONCLUSIONS: The HTGW phenotype is prevalent in the Cree. Our findings support further study on the utility of combining the HTGW with the FRS in the prediction of cardiovascular disease outcomes and in health screening and intervention programs among indigenous peoples.
Authors: Peyman Namdarimoghaddam; Adeleke Fowokan; Karin H Humphries; G B John Mancini; Scott Lear Journal: BMC Cardiovasc Disord Date: 2021-02-02 Impact factor: 2.298
Authors: Dandara Almeida Reis da Silva; Ludmila Santana de Almeida; Livia Lugarinho Correa; Rodrigo Fernandes Weyll Pimentel; Antonio Marcos Tosoli Gomes; Ana Gabriela Travassos; Adriana Mattos Viana; Monique Magnavita Borba da Fonseca Cerqueira; Marcio Costa de Souza; Anderson Reis de Sousa; Paulo José Bastos Barbosa; Julita Maria Freitas Coelho; Lucelia Batista Neves Cunha Magalhães; Argemiro D'Oliveira Júnior; Jorge Lopes Cavalcante Neto; Charles Souza Santos; Luiz Carlos Moraes França; Juliana de Lima Brandão; Livia Fajin de Mello Dos Santos; Helena Ferraz Gomes; Ellen Marcia Peres; Thais Regis Aranha Rossi; Kairo Silvestre Meneses Damasceno; Millena Conceição das Mercês; Sandra Lúcia Fernandes; Eline de Almeida Soriano; Isolda Prado de Negreiros Nogueira Maduro; Tatiana Santos Brandão; Amanda Cardoso Menezes; Amália Ivine Costa Santana; Magno Conceição das Merces Journal: Int J Environ Res Public Health Date: 2022-08-17 Impact factor: 4.614
Authors: Luiza Delazari Borges; Luma de Oliveira Comini; Laura Camargo de Oliveira; Heloísa Helena Dias; Emily de Souza Ferreira; Clara Regina Santos Batistelli; Glauce Dias da Costa; Tiago Ricardo Moreira; Rodrigo Gomes da Silva; Rosângela Minardi Mitre Cotta Journal: J Nutr Sci Date: 2021-09-14